We examine the mountaineering career of the Duke of Abruzzi, who was born on this day in 1873. The energetic royal was ...

BOSTON, Jan. 10, 2025 (GLOBE NEWSWIRE) -- Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines ...

“Last year was transformative for Monte Rosa, with significant validation of our capabilities to design and develop ‘only-in-class’ MGDs for previously undruggable targets across a broad ...

https://www.tipranks.com/news/the-fly/intuitive-surgical-price-target-raised-to-622-from-561-at-btig Monte Rosa Therapeutics (GLUE) outlined anticipated 2025 ...

The lengthening list of pharma alliances focused on molecular glue degraders has another entry after Novartis signed a deal with Monte Rosa Therapeutics worth up to $2.2 billion. The partnership ...

Newly opened Rosa’s Pastry, a Middle Eastern bakery and coffee shop at 4430 US-90 in Pace, not only carries the viral stuffed chocolate − along with a homemade Dubai chocolate cheesecake − ...

Roche seems determined to develop a commanding position in the emerging molecular glue category, signing up to a $2 billion partnership with Monte Rosa Therapeutics that includes a $50 million ...

Old-vine California Cabernet has never been in higher demand, and we just got a preview tasting of some of the state's newest bottlings ...

Last year featured slower merger and acquisition (M&A) activity than 2023 and a moderate uptick in alliances. Here, we highlight the trends and key deals. The transactions analysed include those ...